Wolverine Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.7M | Buy |
50,500
+14,500
| +40% | +$724K | ﹤0.01% | 1914 |
|
|
2025
Q2 | $1.93M | Sell |
36,000
-14,300
| -28% | -$726K | ﹤0.01% | 1733 |
|
|
2025
Q1 | $2.2M | Sell |
50,300
-38,500
| -43% | -$1.95M | ﹤0.01% | 1556 |
|
|
2024
Q4 | $4.99M | Buy |
88,800
+34,300
| +63% | +$2.13M | ﹤0.01% | 1212 |
|
|
2024
Q3 | $3.59M | Buy |
54,500
+18,400
| +51% | +$1.04M | ﹤0.01% | 1276 |
|
|
2024
Q2 | $1.53M | Sell |
36,100
-26,900
| -43% | -$1.48M | ﹤0.01% | 1805 |
|
|
2024
Q1 | $4.35M | Buy |
63,000
+16,900
| +37% | +$1.07M | ﹤0.01% | 1095 |
|
|
2023
Q4 | $3.41M | Buy |
+46,100
| New | +$3.02M | ﹤0.01% | 1329 |
|
|
2023
Q3 | – | Sell |
-79,700
| Closed | -$7.51M | – | 4665 |
|
|
2023
Q2 | $7.51M | Buy |
79,700
+44,400
| +126% | +$3.46M | 0.01% | 701 |
|
|
2023
Q1 | $2.34M | Sell |
35,300
-21,700
| -38% | -$1.39M | ﹤0.01% | 1278 |
|
|
2022
Q4 | $2.82M | Buy |
57,000
+7,300
| +15% | +$298K | ﹤0.01% | 1193 |
|
|
2022
Q3 | $1.65M | Buy |
+49,700
| New | +$2.05M | ﹤0.01% | 1546 |
|
|
2022
Q2 | – | Sell |
-41,400
| Closed | -$2.95M | – | 4857 |
|
|
2022
Q1 | $2.95M | Sell |
41,400
-48,000
| -54% | -$3.51M | ﹤0.01% | 1430 |
|
|
2021
Q4 | $6.96M | Buy |
89,400
+16,500
| +23% | +$1.46M | 0.01% | 930 |
|
|
2021
Q3 | $6.68M | Buy |
72,900
+22,100
| +44% | +$2.33M | 0.01% | 1088 |
|
|
2021
Q2 | $6.51M | Sell |
50,800
-13,800
| -21% | -$1.65M | 0.01% | 940 |
|
|
2021
Q1 | $7.99M | Sell |
64,600
-9,900
| -13% | -$1.36M | 0.01% | 825 |
|
|
2020
Q4 | $10.1M | Buy |
74,500
+6,800
| +10% | +$822K | 0.02% | 667 |
|
|
2020
Q3 | $6.91M | Buy |
67,700
+8,600
| +15% | +$743K | 0.02% | 688 |
|
|
2020
Q2 | $5.08M | Buy |
59,100
+4,300
| +8% | +$344K | 0.01% | 797 |
|
|
2020
Q1 | $3.2M | Sell |
54,800
-41,400
| -43% | -$3.36M | 0.01% | 1009 |
|
|
2019
Q4 | $8.84M | Buy |
96,200
+18,100
| +23% | +$1.59M | 0.02% | 735 |
|
|
2019
Q3 | $7.18M | Buy |
78,100
+11,600
| +17% | +$1.32M | 0.02% | 679 |
|
|
2019
Q2 | $7.85M | Buy |
66,500
+18,400
| +38% | +$1.85M | 0.02% | 652 |
|
|
2019
Q1 | $4.17M | Sell |
48,100
-24,800
| -34% | -$2.11M | 0.01% | 998 |
|
|
2018
Q4 | $4.46M | Buy |
72,900
+16,600
| +29% | +$1.14M | 0.01% | 886 |
|
|
2018
Q3 | $4.44M | Buy |
56,300
+11,400
| +25% | +$743K | 0.01% | 1055 |
|
|
2018
Q2 | $1.81M | Hold |
44,900
| – | – | ﹤0.01% | 1680 |
|
|
2018
Q1 | $1.81M | Sell |
44,900
-27,100
| -38% | -$1.32M | ﹤0.01% | 1680 |
|
|
2017
Q4 | $3.78M | Buy |
72,000
+17,000
| +31% | +$908K | 0.01% | 1058 |
|
|
2017
Q3 | $2.59M | Sell |
55,000
-36,400
| -40% | -$1.47M | 0.01% | 1167 |
|
|
2017
Q2 | $3.26M | Buy |
91,400
+42,300
| +86% | +$1.31M | 0.02% | 919 |
|
|
2017
Q1 | $1.16M | Buy |
49,100
+12,300
| +33% | +$244K | 0.01% | 1607 |
|
|
2016
Q4 | $492K | Sell |
36,800
-23,700
| -39% | -$383K | ﹤0.01% | 2643 |
|
|
2016
Q3 | $1.07M | Sell |
60,500
-6,600
| -10% | -$116K | 0.01% | 1794 |
|
|
2016
Q2 | $758K | Buy |
+67,100
| New | +$505K | ﹤0.01% | 1829 |
|
Other funds holding EXAS
Wolverine Trading's EXAS Position: Q3 2025 in Review
Wolverine Trading reduced its Exact Sciences (EXAS) stake by 46% in Q3 2025, selling an estimated $557K and leaving 12,906 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #3317.
Wolverine Trading first reported a position in EXAS in Q2 2016 and has held it in 30 quarters since. The position peaked at $2.85M in Q4 2017. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.
- Wolverine Trading held 12,906 shares of Exact Sciences worth $689K as of Q3 2025.
- Wolverine Trading sold 11,155 Exact Sciences shares in Q3 2025, an estimated $557K.
- Exact Sciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3317 holding.
- Wolverine Trading first reported a position in Exact Sciences in Q2 2016 and has held it in 30 quarters since.
- Wolverine Trading's Exact Sciences position peaked at $2.85M in Q4 2017.
- 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.